GlassScriptPhysician profile
Sarah B Swiatowicz
NPI 1649532201
$2,202.28
in general payments reported to CMS, 2019-2025
28 companies · $686 in 2025
The $686 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $38.66 · 2022: $242 · 2023: $592 · 2024: $644 · 2025: $686.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,921.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,921.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $338.08 | 2022-2025 | |
| Abbott Laboratories | $243.98 | 2022-2025 | Freestyle Libre 3 |
| Lilly USA, LLC | $236.49 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $214.94 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $175.04 | 2022-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $112.34 | 2023-2025 | Farxiga, Airsupra, Flumist Quadrivalent |
| Daiichi Sankyo INC. | $93.12 | 2024-2025 | Injectafer |
| Abbvie INC. | $86.71 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $75.91 | 2022-2023 | |
| Exact Sciences Corporation | $67.67 | 2023-2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $65.48 | 2023-2025 | Capvaxive, Gardasil 9, Verquvo |
| Edwards Lifesciences Corporation | $63.59 | 2025 | Sapien 3 Ultra Resilia |
| Medtronic, INC. | $48.20 | 2023-2025 | Cd Horizon Spinal System, Venaseal, Inceptiv |
| Sanofi-Aventis U.S. LLC | $44.19 | 2023-2024 | |
| Xeris Pharmaceuticals, INC. | $35.73 | 2022-2025 | Gvoke Hypopen |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $33.03 | 2022 | |
| Janssen Pharmaceuticals, INC | $31.67 | 2022-2025 | Spravato |
| Amgen INC. | $28.65 | 2025 | Otezla, Repatha |
| Aimmune Therapeutics, INC. | $26.70 | 2024 | |
| Inspire Medical Systems, INC. | $25.03 | 2024 | Inspire |
| Organogenesis INC. | $23.14 | 2025 | Apligraf |
| Radius Health, INC. | $22.58 | 2025 | |
| Sanofi Pasteur INC. | $21.30 | 2023 | |
| Alk-Abello, INC | $20.91 | 2025 | Grastek, Ragwitek |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.86 | 2024 | Jardiance |
| Horizon Therapeutics Plc | $18.63 | 2021 | |
| Global Blood Therapeutics, INC. | $15.34 | 2022 | |
| Esperion Therapeutics, INC. | $14.97 | 2024 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Swiatowicz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.